DK0455769T3 - Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker - Google Patents
Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos menneskerInfo
- Publication number
- DK0455769T3 DK0455769T3 DK90917032.6T DK90917032T DK0455769T3 DK 0455769 T3 DK0455769 T3 DK 0455769T3 DK 90917032 T DK90917032 T DK 90917032T DK 0455769 T3 DK0455769 T3 DK 0455769T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzopyrone
- human
- magline
- tumors
- medicament
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 229960000956 coumarin Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 abstract 2
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 abstract 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 abstract 1
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010038389 Renal cancer Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 abstract 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 abstract 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 201000005296 lung carcinoma Diseases 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 201000001514 prostate carcinoma Diseases 0.000 abstract 1
- 201000010174 renal carcinoma Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 201000000849 skin cancer Diseases 0.000 abstract 1
- 201000008261 skin carcinoma Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 abstract 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Monitoring And Testing Of Nuclear Reactors (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3938902A DE3938902C1 (fr) | 1989-11-24 | 1989-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0455769T3 true DK0455769T3 (da) | 1996-02-05 |
Family
ID=6394102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90917032.6T DK0455769T3 (da) | 1989-11-24 | 1990-11-23 | Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0455769B1 (fr) |
| JP (1) | JP3053645B2 (fr) |
| KR (1) | KR0177821B1 (fr) |
| AT (1) | ATE128354T1 (fr) |
| AU (1) | AU6739690A (fr) |
| BR (1) | BR9007080A (fr) |
| CA (1) | CA2045593C (fr) |
| DE (2) | DE3938902C1 (fr) |
| DK (1) | DK0455769T3 (fr) |
| FI (1) | FI913531A7 (fr) |
| WO (1) | WO1991007959A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2822379B1 (fr) * | 2001-03-20 | 2007-06-15 | Sederma Sa | Compositions cosmetiques et dermopharmaceutiques contenant de l'umbelliferone |
| US7148252B2 (en) * | 2001-10-03 | 2006-12-12 | Signal Pharmaceuticals, Llc | Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096887A (en) * | 1984-03-01 | 1992-03-17 | Lamorna Investments Proprietary Limited | Treatment of high protein oedemas |
-
1989
- 1989-11-24 DE DE3938902A patent/DE3938902C1/de not_active Expired - Lifetime
-
1990
- 1990-11-23 FI FI913531A patent/FI913531A7/fi not_active Application Discontinuation
- 1990-11-23 CA CA002045593A patent/CA2045593C/fr not_active Expired - Lifetime
- 1990-11-23 EP EP90917032A patent/EP0455769B1/fr not_active Expired - Lifetime
- 1990-11-23 AT AT90917032T patent/ATE128354T1/de not_active IP Right Cessation
- 1990-11-23 AU AU67396/90A patent/AU6739690A/en not_active Abandoned
- 1990-11-23 JP JP2515771A patent/JP3053645B2/ja not_active Expired - Fee Related
- 1990-11-23 DE DE59009724T patent/DE59009724D1/de not_active Expired - Fee Related
- 1990-11-23 WO PCT/EP1990/002003 patent/WO1991007959A1/fr not_active Ceased
- 1990-11-23 DK DK90917032.6T patent/DK0455769T3/da active
- 1990-11-23 BR BR909007080A patent/BR9007080A/pt not_active Application Discontinuation
-
1991
- 1991-07-22 KR KR1019910700768A patent/KR0177821B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR9007080A (pt) | 1991-12-24 |
| FI913531A0 (fi) | 1991-07-23 |
| CA2045593A1 (fr) | 1991-05-25 |
| CA2045593C (fr) | 2000-09-05 |
| DE3938902C1 (fr) | 1991-05-08 |
| KR920700636A (ko) | 1992-08-10 |
| EP0455769B1 (fr) | 1995-09-27 |
| JPH04505020A (ja) | 1992-09-03 |
| WO1991007959A1 (fr) | 1991-06-13 |
| ATE128354T1 (de) | 1995-10-15 |
| FI913531A7 (fi) | 1991-07-23 |
| KR0177821B1 (en) | 1999-03-20 |
| JP3053645B2 (ja) | 2000-06-19 |
| AU6739690A (en) | 1991-06-26 |
| DE59009724D1 (de) | 1995-11-02 |
| EP0455769A1 (fr) | 1991-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20094798B (en) | (s,s)-reboxetine for treating chronic pain | |
| PT933995E (pt) | Metodo para tratamento de lesao endotelial | |
| IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
| TR200201442T2 (tr) | Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı. | |
| EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| MY121548A (en) | Compounds and methods for the treatment of cancer | |
| DK209088A (da) | Medicinpraeparater, deres fremstilling og anvendelse | |
| IT8419266A0 (it) | Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori. | |
| GR3036686T3 (en) | Therapeutic uses of bactericidal/permeability increasing protein products | |
| NZ332720A (en) | Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia | |
| NO158741C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere. | |
| DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
| CY1105818T1 (el) | Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου | |
| BR0115162A (pt) | Tratamentos antitumorais eficazes | |
| HUP9900905A2 (hu) | D4-Vitamin származékok alkalmazása rák kezelésére szolgáló gyógyászati készítmények előállítására | |
| AU1206292A (en) | Therapeutic agents for the treatment of multidrug resistance to cancers | |
| EP0511306A4 (en) | Tumor killing effects of enterotoxins and related compounds | |
| EP0347899A3 (en) | Pharmaceutical compositions on egg shell basis and their preparation and use | |
| DE60116075D1 (de) | Behandlung von tumoren mit photodynamischer therapie | |
| ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
| DK0455769T3 (da) | Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker | |
| DK0588477T3 (da) | Medicinsk præparat omfatende TCF-11 | |
| FI810380L (fi) | Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen | |
| MX9200755A (es) | Tratamiento de carcinoma pulmonar de celulas no pequeñas. | |
| EP0321094A3 (fr) | Traitement des inhibiteurs de facteur VIII |